InvestorsObserver
×
News Home

Should You Buy AstraZeneca plc (AZN) in Drug Manufacturers - General Industry?

Monday, May 16, 2022 06:55 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Buy AstraZeneca plc (AZN) in Drug Manufacturers - General Industry?

AstraZeneca plc (AZN) leads the Drug Manufacturers - General industry with an overall score of 79. AZN is up 12.99% so far this year after the company closed yesterday at $63.14. The overall score measures the company's performance based-off both short and long term indicators and means that AZN scores better than 79% of the overall market.

Overall Score - 79
AZN has an Overall Score of 79. Find out what this means to you and get the rest of the rankings on AZN!
AstraZeneca plc is a strong performer in the Drug Manufacturers - General industry, which has an average overall score of 51. This means that, on average, the stocks in this industry score higher than 51% of the stock market.
To see InvestorsObserver's Sentiment Score for AstraZeneca plc click here. AZN has been trading neutral recently. The stock is trading up 0.89% this week following yesterday's decline. AZN has an average analyst ranking of Strong Buy with an average price target of $74.25. Click Here to get the full Stock Report for AstraZeneca plc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App